Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
asenapine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.06 approved antagonist
asenapine alpha-2a adrenergic receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.07 approved antagonist
asenapine alpha-2b adrenergic receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.09 approved antagonist
asenapine alpha-2c adrenergic receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.08 approved antagonist
asenapine beta-1 adrenergic receptor small molecule NA drugbank Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist
asenapine beta-2 adrenergic receptor small molecule NA drugbank Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist
asenapine dopamine d1 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.06 approved antagonist
asenapine dopamine d2 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.11 approved antagonist
asenapine dopamine d3 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.15 approved antagonist
asenapine dopamine d4 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.2 approved antagonist
asenapine histamine h1 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.08 approved antagonist
asenapine histamine h2 receptor small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.37 approved antagonist
asenapine 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.12 approved antagonist,agonist
asenapine 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.12 approved antagonist
asenapine 5-hydroxytryptamine receptor 1b small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.2 approved antagonist
asenapine 5-hydroxytryptamine receptor 1b small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.2 approved antagonist,agonist
asenapine 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.11 approved antagonist
asenapine 5-hydroxytryptamine receptor 2b small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.14 approved antagonist
asenapine 5-hydroxytryptamine receptor 2c small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.13 approved antagonist
asenapine 5-hydroxytryptamine receptor 5a small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.68 approved antagonist
asenapine 5-hydroxytryptamine receptor 6 small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.3 approved antagonist
asenapine 5-hydroxytryptamine receptor 7 small molecule NA drugbank , DGIDB Manic Disorder[MeSHID:D001714]
Schizophrenia[MeSHID:D012559]
Psychotic Disorders[MeSHID:D011618]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.2 approved antagonist
click here to return to the previous page